Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Macaca mulatta | 6 | 2021 | 3716 | 0.71 | Why? |
| Antigens, Differentiation | 1 | 2018 | 172 | 0.65 | Why? |
| Immunity, Humoral | 11 | 2021 | 4849 | 0.62 | Why? |
| Antigens, Surface | 1 | 2017 | 181 | 0.61 | Why? |
| Immunity, Cellular | 7 | 2021 | 3614 | 0.60 | Why? |
| HIV-1 | 4 | 2019 | 3365 | 0.55 | Why? |
| Vaccines, DNA | 2 | 2020 | 871 | 0.54 | Why? |
| RNA-Binding Proteins | 2 | 2018 | 1022 | 0.52 | Why? |
| Membrane Proteins | 3 | 2019 | 1733 | 0.45 | Why? |
| Viral Vaccines | 6 | 2021 | 7560 | 0.38 | Why? |
| Virus Internalization | 2 | 2018 | 7921 | 0.37 | Why? |
| Gene Knockdown Techniques | 2 | 2018 | 347 | 0.32 | Why? |
| Adenoviridae | 2 | 2021 | 1151 | 0.28 | Why? |
| Interferons | 1 | 2017 | 2885 | 0.27 | Why? |
| Bronchoalveolar Lavage Fluid | 3 | 2021 | 2309 | 0.25 | Why? |
| Immunogenicity, Vaccine | 4 | 2021 | 4624 | 0.24 | Why? |
| Spike Glycoprotein, Coronavirus | 10 | 2021 | 37182 | 0.23 | Why? |
| Antibodies, Viral | 14 | 2021 | 51949 | 0.22 | Why? |
| Receptors, Virus | 1 | 2018 | 5659 | 0.22 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.22 | Why? |
| Antibodies, Neutralizing | 14 | 2021 | 25288 | 0.21 | Why? |
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 30 | 0.20 | Why? |
| Mutant Proteins | 1 | 2020 | 328 | 0.19 | Why? |
| Receptors, CXCR4 | 1 | 2018 | 83 | 0.18 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2019 | 86 | 0.18 | Why? |
| Jaagsiekte sheep retrovirus | 1 | 2017 | 2 | 0.17 | Why? |
| Disease Models, Animal | 6 | 2020 | 10998 | 0.17 | Why? |
| HIV Long Terminal Repeat | 1 | 2017 | 16 | 0.17 | Why? |
| THP-1 Cells | 1 | 2018 | 374 | 0.17 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.17 | Why? |
| Virion | 3 | 2021 | 1444 | 0.17 | Why? |
| HIV Infections | 3 | 2019 | 11620 | 0.17 | Why? |
| Protein Domains | 2 | 2020 | 6563 | 0.16 | Why? |
| Receptors, IgG | 1 | 2020 | 578 | 0.16 | Why? |
| Receptors, CCR5 | 1 | 2018 | 186 | 0.16 | Why? |
| Nasal Mucosa | 2 | 2020 | 1218 | 0.15 | Why? |
| GPI-Linked Proteins | 1 | 2017 | 317 | 0.15 | Why? |
| Polyproteins | 1 | 2018 | 814 | 0.15 | Why? |
| Nose | 1 | 2021 | 1093 | 0.14 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.14 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.14 | Why? |
| Leukocytes, Mononuclear | 3 | 2021 | 2115 | 0.13 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.13 | Why? |
| RNA, Small Interfering | 1 | 2018 | 817 | 0.13 | Why? |
| Milk, Human | 1 | 2021 | 956 | 0.12 | Why? |
| Immunization, Secondary | 1 | 2020 | 1649 | 0.12 | Why? |
| Immunoglobulin A | 2 | 2020 | 3567 | 0.12 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.11 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.11 | Why? |
| Adjuvants, Immunologic | 1 | 2020 | 1709 | 0.10 | Why? |
| Animals | 9 | 2021 | 78931 | 0.10 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.10 | Why? |
| Viral Load | 5 | 2020 | 15850 | 0.10 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.09 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.08 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.07 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.07 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.07 | Why? |
| Male | 16 | 2021 | 367725 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Vaccines, Synthetic | 3 | 2021 | 3231 | 0.06 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.06 | Why? |
| Genetic Vectors | 2 | 2020 | 1600 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| HL-60 Cells | 1 | 2020 | 60 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.05 | Why? |
| Adoptive Transfer | 1 | 2020 | 250 | 0.05 | Why? |
| Vaccine Potency | 1 | 2021 | 339 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.05 | Why? |
| Lactation | 1 | 2021 | 361 | 0.05 | Why? |
| Vesiculovirus | 1 | 2018 | 153 | 0.04 | Why? |
| Humans | 17 | 2021 | 930598 | 0.04 | Why? |
| Protein Transport | 1 | 2019 | 487 | 0.04 | Why? |
| Primates | 1 | 2020 | 584 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Dried Blood Spot Testing | 1 | 2020 | 383 | 0.04 | Why? |
| HIV Seropositivity | 1 | 2019 | 320 | 0.04 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.04 | Why? |
| Animal Husbandry | 1 | 2017 | 162 | 0.04 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.04 | Why? |
| Viral Envelope Proteins | 2 | 2018 | 3539 | 0.04 | Why? |
| Amino Acid Motifs | 1 | 2017 | 620 | 0.04 | Why? |
| Mesocricetus | 1 | 2020 | 1847 | 0.04 | Why? |
| Receptors, Cell Surface | 1 | 2019 | 586 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| HEK293 Cells | 2 | 2019 | 8394 | 0.03 | Why? |
| Adult | 9 | 2021 | 244371 | 0.03 | Why? |
| Cell Membrane | 1 | 2019 | 743 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2019 | 501 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.03 | Why? |
| Down-Regulation | 1 | 2019 | 1416 | 0.03 | Why? |
| Cricetinae | 1 | 2020 | 3344 | 0.03 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.03 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2019 | 2273 | 0.02 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Immune Evasion | 1 | 2017 | 2081 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2019 | 11041 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.01 | Why? |
| Italy | 1 | 2017 | 38444 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Yu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(249)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_